BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22462607)

  • 21. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
    Ørsted DD; Bojesen SE; Nielsen SF; Nordestgaard BG
    Eur Urol; 2011 Oct; 60(4):691-8. PubMed ID: 21705134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
    Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
    BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of selenium status, dietary glucosinolate intake and serum glutathione S-transferase α activity on the risk of benign prostatic hyperplasia.
    Eichholzer M; Steinbrecher A; Kaaks R; Teucher B; Linseisen J; Rohrmann S
    BJU Int; 2012 Dec; 110(11 Pt C):E879-85. PubMed ID: 22882569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
    Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
    BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
    Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
    Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammatory changes in the obstructed prostate: the correlation between the bacteriological and histological findings].
    Soler Soler JL; Martínez Torres JL; Hidalgo Domínguez Mdel R; Lardelli Claret P; Liébana Ureña J; Zuluaga Gómez A; Saharour G
    Arch Esp Urol; 1999 Sep; 52(7):729-38. PubMed ID: 10540763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal cell hyperplasia in the peripheral zone of the prostate.
    Thorson P; Swanson PE; Vollmer RT; Humphrey PA
    Mod Pathol; 2003 Jun; 16(6):598-606. PubMed ID: 12808066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate inflammation. Association with benign prostatic hyperplasia and prostate cancer.
    Abdel-Meguid TA; Mosli HA; Al-Maghrabi JA
    Saudi Med J; 2009 Dec; 30(12):1563-7. PubMed ID: 19936421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.
    Lee JS; Loh TH; Seow SC; Tan SH
    J Am Acad Dermatol; 2007 Jun; 56(6):994-1005. PubMed ID: 17504716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
    J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation.
    Descazeaud A; Weinbreck N; Robert G; Vacherot F; Abbou CC; Labrousse F; Allory Y; Rubin MA; de la Taille A
    BJU Int; 2011 Jul; 108(2 Pt 2):E23-8. PubMed ID: 20840324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia.
    McNeal J; Noldus J
    Urology; 1996 Nov; 48(5):751-6. PubMed ID: 8911519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association study between benign prostatic hyperplasia and primary hypertension].
    Guo LJ; Zhang XH; Li PJ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):108-11. PubMed ID: 15771818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacterial content of the enucleated prostate gland].
    Soler Soler JL; Hidalgo Domínguez MR; Zuluaga Gómez A; Martínez Torres JL; Lardelli Claret P; Liébana Ureña J; Saharour G
    Arch Esp Urol; 1999 Oct; 52(8):823-34. PubMed ID: 10589113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.